Skip to main content

Advertisement

Table 2 Logistic regression analysis of survial time after double stenting

From: Efficacy and safety of chemotherapy after endoscopic double stenting for malignant duodenal and biliary obstructions in patients with advanced pancreatic cancer: a single-institution retrospective analysis

  Univariable analysis Multivariable analysis
Variable OR (95% CI) P value OR (95% CI) P value
Age (≥65) 0.79 (0.43–1.42) 0.43   
Gender (M) 0.77 (0.40–1.53) 0.45   
Distant metastaisis at initial diagnosis (yes) 1.26 (0.69–2.42) 0.46   
Timing of double stenting (Simultaneous) 0.64 (0.34–1.17) 0.15   
Type of stent (PS) 0.43 (0.19–0.87) 0.018 0.82 (0.29–2.05) 0.68
Biliary drainage method (EUS-BD) 0.29 (0.13–0.57) 0.0002 0.45 (0.16–1.13) 0.093
Reintervention for DU stent dysfunction (yes) 0.24 (0.078–0.59) 0.0012 0.42 (0.098–1.54) 0.19
Reintervention for BS dysfunction (yes) 0.33 (0.15–0.68) 0.0018 0.21 (0.081–0.50) 0.0002
Chemotherapy post double stenting (yes) 0.14 (0.067–0.30) <.0001 0.19 (0.059–0.60) 0.0051
Performance status (< 2) 0.11 (0.048–0.23) <.0001 0.28 (0.098–0.71) 0.0064
  1. OR odds ratio, CI confidence interval, PS plastic stent, EUS-BD endoscopic ultrasound-guided biliary drainage, DU duodenal stent, BS biliary stent